About
The global index of cancer
CancerIndex is a provenance-first, continuously updated, transparently sourced index of every recognized malignant disease entity — not a list of thirty common cancers.
Scope
What it connects
Taxonomy (NCIt, OncoTree, ICD), epidemiology (registries), genomics (open cohorts), variants and curated evidence (CIViC, ClinVar), therapies and regulatory status (by jurisdiction), clinical trials (ClinicalTrials.gov), and literature (PubMed) — linked through stable public identifiers and explicit match types.
Audience
Who it is for
Researchers, clinicians, analysts, journalists, patient advocates and developers who need the number and where it came from. The public API mirrors the site so nothing on the page is unavailable programmatically.
Principles
What it refuses to do
- No number without a source, a retrieval date and — when derived — a formula version.
- No invented, estimated or placeholder statistics. Missing data is shown as missing.
- No composite "worst cancer" score that hides its weights.
- No medical advice: CancerIndex is not a physician, does not diagnose and does not recommend treatment.
- No AI-generated synthesis in this phase; all text is sourced or fixed methodology.
Who
Who builds and hosts it
CancerIndex is designed, built and maintained by Simon-Pierre Boucher. Questions, corrections, licensing concerns and collaboration requests: contact@spboucher.ai.
The platform — database, ingestion workers, API and web application — is hosted on MacLustr (www.maclustr.io), a private Apple-silicon compute cluster, and published through the MacLustr Tunnel.
Status
Phase 1
The taxonomy backbone is live; epidemiology, genomics, trial and literature connectors are being brought online one at a time, each after a license review. Follow progress on the source registry and read the methodology.